Zimmer Biomet Holdings (MIL:1ZBH) Cyclically Adjusted PS Ratio: (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1ZBH Zimmer Biomet Holdings Inc MIL:1ZBH
53 GF Score
Price €83.36
GF Value €108.79
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Zimmer Biomet Holdings  (MIL:1ZBH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Related Terms


Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Chart

Zimmer Biomet Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.34 3.24 2.99 2.51 2.09

Zimmer Biomet Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.11 2.28 2.09 2.07 0.00

MIL:1ZBH vs STE, PEN, PODD: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zimmer Biomet Holdings Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio falls into.


MIL:1ZBH
53GF Score
Zimmer Biomet Holdings Inc MIL:1ZBH
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Zimmer Biomet Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Zimmer Biomet Holdings's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=9.801/333.9520*333.9520
=9.801

Current CPI (Jun. 2026) = 333.9520.

Zimmer Biomet Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 8.048 241.428 11.132
201612 9.343 241.432 12.923
201703 9.080 243.801 12.438
201706 8.518 244.955 11.613
201709 7.457 246.819 10.089
201712 8.567 246.524 11.605
201803 7.997 249.554 10.702
201806 8.399 251.989 11.131
201809 7.663 252.439 10.137
201812 8.919 251.233 11.856
201903 8.495 254.202 11.160
201906 8.535 256.143 11.128
201909 8.301 256.759 10.797
201912 9.202 256.974 11.959
202003 7.818 258.115 10.115
202006 5.265 257.797 6.820
202009 7.856 260.280 10.080
202012 4.705 260.474 6.032
202103 6.400 264.877 8.069
202106 6.946 271.696 8.538
202109 6.802 274.310 8.281
202112 7.486 278.802 8.967
202203 7.188 287.504 8.349
202206 8.015 296.311 9.033
202209 8.019 296.808 9.023
202212 8.181 296.797 9.205
202303 8.128 301.836 8.993
202306 8.221 305.109 8.998
202309 7.824 307.789 8.489
202312 8.533 306.746 9.290
202403 8.429 312.332 9.012
202406 8.741 314.175 9.291
202409 8.097 315.301 8.576
202412 9.661 315.605 10.223
202503 8.843 319.799 9.234
202506 9.082 322.561 9.403
202509 8.577 324.800 8.819
202512 9.687 324.054 9.983
202603 9.219 330.213 9.323
202606 9.801 333.952 9.801

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Zimmer Biomet Holdings (MIL:1ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of €83.36 is trading 23.4% below its estimated GF Value™ of €108.79. GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.

Key valuation signals for MIL:1ZBH:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €108.79 vs. price of €83.36 (23.4% below fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the MIL:1ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
53GF Score

Get the complete analysis for MIL:1ZBH

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€83.36
Price
€108.79
GF Value